Sort   by:  
 Page size 
UnknownIntravesical rAd-IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study.
Not available
S-EPMC5648171 | biostudies-literature
GenomicsWhole-Genome and Exome Sequencing in clear-cell Renal Cell Carcinoma (ccRCC)

Study to evaluate the molecular genetics of ccRCC through integrative analyses of tumors and tumorgrafts using multiple platforms in clinically annotated samples. Genome and exome data for patients giving consent to have the information available on a public, secure, database is being submitted.<...

phs000491.v1.p1 | EGA
Genomicsena-DATASET-Genentech-07-10-2014-17:32:07:354-3 - samples
nccRCC Whole Exome sequencing data (consented samples only)
EGAD00001001023 | EGA
GenomicsnccRCC_Illumina_2.5M - samples
nccRCC tumor/normal genotypes
EGAD00010000648 | EGA
Genomicsena-DATASET-Genentech-07-10-2014-17:28:50:781-2 - samples
nccRCC RNA-Seq data of consented samples
EGAD00001001022 | EGA
Genomicsena-DATASET-Genentech-27-10-2014-16:49:10:053-281 - samples
Targeted exome sequencing of 375 genes
EGAD00001001047 | EGA
GenomicsStudy of non-clear cell renal cell carcinoma
Study of non-clear cell renal cell carcinoma
EGAS00001000926 | EGA
GenomicsGenentech RCC DAC
Data Access Committee EGAC00001000247
EGAC00001000247 | EGA
ProteomicsLabel-free global proteome profiling of European American and African American bladder tumor patients.
Bladder cancer (BLCA) mortality is higher in African American (AA) patients compared to their European American (EA) counterparts, but the molecular mechanism underlying differences are unknown. . Thus, we performed proteomics analysis of AA and EA BLCA and identified higher mitochondrial OXPHOS spe...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2024-08-08 | MSV000095559 | MassIVE
Sort   by:  
 Page size